Biohaven (BHVN) Gains from Investment Securities (2021 - 2026)
Biohaven has reported Gains from Investment Securities over the past 6 years, most recently at $837000.0 for Q1 2026.
- Quarterly results put Gains from Investment Securities at $837000.0 for Q1 2026, down 70.57% from a year ago — trailing twelve months through Mar 2026 was -$158000.0 (down 101.17% YoY), and the annual figure for FY2025 was $1.8 million, down 84.2%.
- Gains from Investment Securities reached $837000.0 in Q1 2026 per BHVN's latest filing, up from -$3.6 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $38.2 million in Q4 2022 and bottomed at -$4.7 million in Q4 2023.
- Median Gains from Investment Securities over the past 5 years was $1.3 million (2025), compared with a mean of $3.3 million.
- The largest annual shift saw Gains from Investment Securities surged 874.4% in 2023 before it plummeted 171.88% in 2025.
- Over 5 years, Gains from Investment Securities stood at $38.2 million in 2022, then plummeted by 112.3% to -$4.7 million in 2023, then surged by 205.47% to $5.0 million in 2024, then plummeted by 171.88% to -$3.6 million in 2025, then surged by 123.51% to $837000.0 in 2026.
- Business Quant data shows Gains from Investment Securities for BHVN at $837000.0 in Q1 2026, -$3.6 million in Q4 2025, and $1.2 million in Q3 2025.